Crossmark

Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy

Published Online: 2020-01-13

Published Print: 2020-01

Authors

Sami, Shaheedul A.

Darwish, Noureldien H. E.

Barile, Amanda N. M.

Mousa, Shaker A. http://orcid.org/0000-0002-9294-015X
License Information

Text and Data Mining valid from 2020-01-01

Version of Record valid from 2020-01-01
More Information

Article History

First Online: 13 January 2020

Compliance with Ethical Standards

:

: Shaheedul A. Sami declares that he has no conflict of interest.Noureldien H. E. Darwish declares that he has no conflict of interest.Amanda N. M. Barile declares that she has no conflict of interest.Shaker A. Mousa was issued a patent that is owned by NanoPharmaceuticals LLC, and he owns stock in NanoPharmaceuticals LLC, which is developing anticancer drugs.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current